Zobrazeno 1 - 4
of 4
pro vyhledávání: '"HIV-1 latency reversal agents"'
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The main obstacle to cure HIV-1 is the latent reservoir. Antiretroviral therapy effectively controls viral replication, however, it does not eradicate the latent reservoir. Latent CD4+ T cells are extremely rare in HIV-1 infected patients, making pri
Externí odkaz:
https://doaj.org/article/aff97d86d87a4ae484b3cf27ee546180
Publikováno v:
Frontiers in Immunology, 13
The main obstacle to cure HIV-1 is the latent reservoir. Antiretroviral therapy effectively controls viral replication, however, it does not eradicate the latent reservoir. Latent CD4+ T cells are extremely rare in HIV-1 infected patients, making pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bdf3b6a01fa3eb6d3205601af47cba7
https://hdl.handle.net/20.500.11850/572973
https://hdl.handle.net/20.500.11850/572973
Autor:
Gupta, Vipul
The treatment of human immunodeficiency virus (HIV-1) infection faces the challenge of drug resistance. The high mutation rate of HIV-1 allows it to develop resistance against all available drugs. New mechanisms of intervention that do not succumb to
Externí odkaz:
http://etd.iisc.ernet.in/2005/3608
http://etd.iisc.ernet.in/abstracts/4477/G28443-Abs.pdf
http://etd.iisc.ernet.in/abstracts/4477/G28443-Abs.pdf
Autor:
Inderbitzin A; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Life Science Zurich Graduate School, University of Zurich, Zurich, Switzerland., Loosli T; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Life Science Zurich Graduate School, University of Zurich, Zurich, Switzerland., Opitz L; Functional Genomics Center Zurich, Eidgenössische Technische Hochschule (ETH) Zürich/University of Zurich, Zurich, Switzerland., Rusert P; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Metzner KJ; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Aug 26; Vol. 13, pp. 915805. Date of Electronic Publication: 2022 Aug 26 (Print Publication: 2022).